Question 1

What is the catalog number for 1-O-Acetyl-2,3,5-tri-O-benzyl-D-ribofuranose?

Accepted Answer

The catalog number for 1-O-Acetyl-2,3,5-tri-O-benzyl-D-ribofuranose is 292397.

Question 2

What sizes are available for 1-O-Acetyl-2,3,5-tri-O-benzyl-D-ribofuranose?

Accepted Answer

1-O-Acetyl-2,3,5-tri-O-benzyl-D-ribofuranose is available in the following size(s): 100 mg, 250 mg, 500 mg, 1 g, 2 g.

Question 3

How many pack sizes does 1-O-Acetyl-2,3,5-tri-O-benzyl-D-ribofuranose come in?

Accepted Answer

1-O-Acetyl-2,3,5-tri-O-benzyl-D-ribofuranose is available in 5 different pack sizes.

Question 4

Is 1-O-Acetyl-2,3,5-tri-O-benzyl-D-ribofuranose in stock?

Accepted Answer

1-O-Acetyl-2,3,5-tri-O-benzyl-D-ribofuranose is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is the molecular weight of the target protein?

Accepted Answer

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

Question 6

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Question 7

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

1-O-Acetyl-2,3,5-tri-O-benzyl-D-ribofuranose

Product Specifications

Available Sizes

Frequently Asked Questions

Explore Other Products

HSP60 (HSPD1/780), 1mg/mL

CD16 (C16/1045), CF740 conjugate, 0.1mg/mL

GAD2 / GAD65 (GABAergic Neuronal Marker) (GAD2/2362), 0.2mg/mL

Anti-TTF2 Antibody Picoband®

TIMP1 (Colorectal Cancer Biomarker / Marker of Lymph Node Metastasis) (rTIMP1/1710), 0.2mg/mL

MHC II (HLA-DQ) (SPV-L3), CF405M conjugate, 0.1mg/mL